| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT06439381 Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis… |
Trial completed |
| 2026-08-14 | NCT06439381 Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis… |
date change Primary completion moved earlier: 2026-06 -> 2025-12-19 |
| 2026-08-14 | NCT06439381 Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis… |
date change Completion moved earlier: 2026-06 -> 2025-12-19 |
| 2026-08-08 | NCT07708272 QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety… |
overall status: Not Yet Recruiting → Active, Not Recruiting |
| 2026-08-04 | NCT07314060 A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized… |
critical Trial terminated |
| 2026-08-04 | NCT07314060 A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized… |
critical Trial terminated: Due to the company's strategic adjustment in product portfolio, this study has been voluntarily terminated. |
| 2026-08-04 | NCT07314060 A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized… |
date change Primary completion moved earlier: 2026-12 -> 2026-07-30 |
| 2026-08-04 | NCT07314060 A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized… |
date change Completion moved earlier: 2027-07 -> 2026-07-30 |
| 2026-07-30 | NCT06413953 A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors |
Trial sites expanded: 1 -> 12 locations |
| 2026-07-30 | NCT06413953 A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors |
date change Primary completion pushed: 2025-06 -> 2026-10 |
| 2026-07-30 | NCT06413953 A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors |
date change Completion pushed: 2026-12 -> 2027-06 |
| 2026-07-28 | NCT07608666 Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the… |
overall status: Not Yet Recruiting → Active, Not Recruiting |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-07 | NCT07753369 A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus… | Phase 3 | Not Yet Recruiting |
| 2026-08-05 | NCT07747857 A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus… | Phase 1 | Not Yet Recruiting |
| 2026-07-31 | NCT07738679 Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05830500 | Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | Medullary Thyroid Cancer | Recruiting |
| NCT07663331 | A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in… | Adult Non-infectious Uveitis | Recruiting |
| NCT07529925 | A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis | Severe Plaque Psoriasis in Chinese Children | Not Yet Recruiting |
| NCT07564505 | Post - Marketing Case Registration Study on the Safety and Efficacy of Adalimumab… | Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease | Not Yet Recruiting |
| NCT07663526 | Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi® | Crohn's Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT05862337 | Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of… | Hepatocellular Carcinoma | Recruiting |
| NCT06300177 | D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced… | Non Small Cell Lung Cancer | Recruiting |
| NCT06351150 | Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With… | Vasodilatory Shock | Recruiting |
| NCT06900920 | A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune… | Primary Immune Thrombocytopenia | Recruiting |
| NCT06682169 | Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third… | Graft-versus-host Disease | Recruiting |
| NCT06860971 | A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced… | Thyroid Cancer | Recruiting |
| NCT07407803 | Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1… | Plexiform Neurofibroma | Recruiting |
| NCT06475599 | Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial… | Endometrial Cancer | Not Yet Recruiting |
| NCT06469879 | A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung… | Small Cell Lung Cancer Limited Stage | Not Yet Recruiting |
| NCT06561607 | A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus… | Breast Cancer | Not Yet Recruiting |
| NCT04523272 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus… | Advanced Renal Cancer | Active, Not Recruiting |
| NCT06738979 | A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in… | Obesity | Not Yet Recruiting |
| NCT04344158 | A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride… | Advanced Hepatocellular Carcinoma (HCC) | Active, Not Recruiting |
| NCT07147946 | Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With… | Chronic Obstructive Pulmonary Disease | Not Yet Recruiting |
| NCT05365178 | To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus… | HR-positive, HER2-negative Breast Neoplasms | Active, Not Recruiting |
| NCT04854668 | A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line… | Metastatic Colorectal Cancer | Active, Not Recruiting |
| NCT05987358 | A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. | Biliary Carcinoma | Active, Not Recruiting |
| NCT07464587 | Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic… | Chronic Obstructive Pulmonary Disease | Not Yet Recruiting |
| NCT05780567 | Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared… | Breast Cancer | Active, Not Recruiting |
| NCT07569757 | Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma | Multiple Myeloma | Not Yet Recruiting |